Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,427,302 papers from all fields of science
Search
Sign In
Create Free Account
Metastatic Head and Neck Carcinoma
A carcinoma that arises from the head and neck and has spread from the original site of growth to another anatomic site.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Epithelial Cells
Epithelium
Head and neck structure
Malignant Epithelial Cell
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Biweekly cetuximab in combination with platinum and 5-fluorouracil in metastatic head and neck carcinoma.
Z. Surmeli
,
A. Ozveren
,
Ç. Arslan
,
M. Değirmenci
,
B. Karaca
,
R. Uslu
Indian Journal of Cancer
2019
Corpus ID: 96436104
Background and Aim The combination of cetuximab with platinum and 5-fluorouracil (5-FU) chemotherapy prolongs survival in…
Expand
2019
2019
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
H. Bahig
,
F. Aubin
,
+14 authors
P. Wong
BMC Cancer
2019
Corpus ID: 255828776
The efficacy of immunotherapy targeting the PD-1/PD-L1 pathway has previously been demonstrated in metastatic head and neck…
Expand
2018
2018
Targeted therapy in recurrent or metastatic head and neck carcinoma
C. Kainickal
2018
Corpus ID: 196491066
Submit Manuscript | http://medcraveonline.com Abbreviations: R/M: Recurrent and/or Metastatic; HNSSC: Head and Neck Squamous Cell…
Expand
2012
2012
Anti‐EGFR–targeting agents in recurrent or metastatic head and neck carcinoma: A meta‐analysis
F. Petrelli
,
S. Barni
Head and Neck
2012
Corpus ID: 34866719
Anti–epidermal growth factor receptor (EGFR) therapies are effective in head and neck carcinoma. A meta‐analysis was performed to…
Expand
2008
2008
E-cadherin expression in locally advanced (LAHNSCC) or metastatic head and neck carcinoma
E. Saâda
,
F. Ettore
,
+8 authors
F. Peyrade
2008
Corpus ID: 74682156
6038 Background: Loss of E-Cadherin (E-Cad) function or expression has been associated with cell adhesion, cancer progression and…
Expand
2004
2004
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)
J. Janinis
,
G. Stathopoulos
,
+12 authors
G. Fountzilas
Anti-Cancer Drugs
2004
Corpus ID: 33960945
A phase I pharmacokinetics and dose-finding study and a phase II study of the combination of pegylated liposomal doxorubicin HCl…
Expand
2004
2004
Metastatic Head and Neck Carcinoma in a Percutaneous Endoscopic Gastrostomy Site
Adam Attoun
,
C. Glastonbury
,
J. Yee
Otolaryngology Head & Neck Surgery
2004
Corpus ID: 37402318
2004
2004
Phase II study of esorubicin (4′ -deoxydoxorubicin) in locally advanced or metastatic head and neck carcinoma
S. Frustaci
,
G. Gasparini
,
+5 authors
S. Monfardini
Investigational new drugs
2004
Corpus ID: 19632084
Sixteen patients with locally advanced or metastatic head and neck cancer were treated with esorubicin (4t'-deoxydoxorubicin) at…
Expand
1994
1994
Metastatic head and neck carcinoma in a percutaneous gastrostomy site
N. Whear
1994
Corpus ID: 68624997
Review
1992
Review
1992
Chemotherapy in head and neck cancer (I): Management of recurrent or metastatic disease.
V. Gebbia
,
G. Zerillo
,
N. Gebbia
,
B. Agostara
,
A. Callari
,
L. Rausa
Journal of chemotherapy
1992
Corpus ID: 45437386
SummaryThis paper is an up-dated review of the role of systemic chemotherapy in the management of recurrent and/or metastatic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required